Een recente studie in India heeft de vraag weer doen rijzen of het besnijden van de penis
bescherming biedt tegen hiv-infectie. Uit een overzicht van eerdere studies is niet
gebleken dat besnijdenis aantoonbaar bescherming biedt tegen hiv-infectie.2 Sommige
studies suggereren juist een grotere ontvankelijkheid bij besneden mannen.3 Bij de recente
studie in India bleek hiv-infectie acht maal minder voor te komen bij besneden mannen dan
bij onbesneden mannen.
Loraine Day doet weer krasse uitspraken in
deel 2 over het ontstaan van AIDS, de oorzaken van kanker en waarom er nooit iets gevonden
zal worden wat kanker gaat verhelpen, wiegendood, SARS en de vogelgriep.
Gene that governs toxin production in
deadly mold found
For the growing number of people with diminished immune systems -- cancer patients,
transplant recipients, those with HIV/AIDS -- infection by a ubiquitous mold known as
Aspergillus fumigatus can be a death sentence.
An image released Thursday by researchers at the National Institute of Allergy and
Infectious Diseases reveals a vulnerability in the ever-powerful AIDS virus. Unlike the
rest of the mutating virus, one key portion on the surface of HIV has been found to be
stable and, more important, penetrable by the HIV-fighting antibody b12. Lees verder
A compound from olive-pomace oil gets 80
percent slowing down of HIV spread
Researchers from the University of Granada and Hospital Carlos III in Madrid,
verified that maslinic acid -- found in wax from olive skin -- inhibits serin-protease,
the enzyme used by HIV to release itself from the infected cell into the extracellular
environment. Lees verder
Green tea 'may keep HIV at bay'
Drinking green tea could help in the fight against HIV, research suggests.
Scientists found a component called epigallocatechin gallate (EGCG) prevents HIV from
binding to immune system cells by getting there first. [Ben Licher] Lees verder
Transformation for people with AIDS on
the horizon
A major breakthrough for people with AIDS is on the horizon, according to
an editorial in this week's BMJ. Three new drugs are predicted to help transform the
long-term prognosis for people with the AIDS virus, says an editorial in the journal,
which points towards highly promising results from trials of three new drugs. Lees verder
HIV study prompts call for revision of
breastfeeding guidelines
A study by scientists at the Africa Centre for Health and Population
Studies, South Africa, has shown that exclusive breastfeeding can significantly reduce the
risk of HIV transmission from mother to child in infants aged under 6 months when compared
to those also given solid foods or replacement feed (i.e. formula milk). The research,
published today in the Lancet, has implications for people in resource poor settings, such
as in rural Africa.
Taking daily selenium supplements may block the build-up of HIV in a patient's blood,
research suggests. Lees verder
HIV/AIDS: Moving Closer to a Vaccine
One of the Yerkes Research Center’s foremost scientific
goals is the development of an AIDS vaccine that will help end the global epidemic now
affecting more than 42 million people. An HIV/AIDS vaccine developedby Yerkes researchers
shows great promise and currently is in its second clinical trial in human volunteers.
[Leo Bakker] Lees verder
UCLA AIDS Institute Researchers Find a
Peptide That Encourages HIV Infection
UCLA AIDS Institute researchers have discovered that when
a crucial portion of a peptide structure in monkeys that defends against viruses, bacteria
and other foreign invaders is reversed, the peptide actually encourages infection with
HIV. Lees verder
Male circumcision reduces the risk of
becoming infected with HIV, but does not provide complete protection
The Joint United Nations Programme on HIV/AIDS and
its Cosponsors, WHO, UNFPA, UNICEF and the World Bank, note with considerable interest
today’s announcement by the US National Institutes of Health that two trials
assessing the impact of male circumcision on HIV risk are being stopped on the
recommendation of the NIH Data Safety and Monitoring Board (DSMB). The two trials, funded
by the US National Institutes of Health, were carried out in Kisumu, Kenya, among men aged
18-24 years and in Rakai, Uganda, among men aged 15-49 years. The trials, which completed
enrolment of patients in 2005, were stopped by the DSMB evaluating the results of interim
analyses. The role of the DSMB is to assess progress of the trials and recommend whether
to continue, modify or terminate them. Although no detailed results have been released at
this time, the National Institutes of Health statement makes it clear that the studies are
being stopped because they revealed an approximate halving of risk of HIV infection in men
who were circumcised. Lees
verder
Study holds promise for new way
to fight aids
For years researchers have been trying to understand
how a few HIV-infected patients naturally defeat a virus that otherwise overwhelms the
immune system.Last year, a research team at the University of Rochester Medical Center
confirmed that such patients, called long-term non-progressors, maintain higherthan normal
levels of the enzyme called APOBEC-3G (A3G) in their white blood cells, which function to
stave off infections. Now, the same group has teamedup with a structural biologist to
provide the first look at the A3G structure. Such information represents an early step
toward the design of a new classof drugs that could afford to all the same natural
protection enjoyed by few, according to a study published today in The Journal of
Biological Chemistry. Lees verder
Homeopathische oplossing voor aids
?
Peter
Chappell denkt een middel tegen /aids gevonden te hebben. Zijn ervaringen met hiv/aids in
zowel de Westerse Wereld als in Azië en Afrika hebben geleid tot de revolutionaire
ontwikkeling van een middel dat hij PC1 heeft genoemd.
Naast
het First Simillimum, de keuze van het homeopatisch middel volgens de regels van
Hahnemann, heeft Peter Chappell voor ernstige ziekten ,die tot nu toe niet of slecht te
behandelen waren, een Second Simillimum ontwikkeld. Het gaat hier om middelen voor ziekten
als HIV, het Chronisch Vermoeidheids Syndroom, Parkinson en vele andere ernstige ziekten.
Inmiddels heeft Peter zo’n 90 verschillende middelen ontwikkeld. Volgens enkele
vooraanstaande homeopaten ligt hierin de toekomst van de homeopathie.
Vaginal Washing Increases Risk of
HIV-1 Acquisition Among African Women: a 10 Year Prospective Study
Sex workers who perform vaginal washing using water
have 3 times the risk of acquiring HIV-1 compared with those that do not perform vaginal
washing at all. Those who used soap for vaginal washing had almost 4 times the risk of
becoming infected with HIV-1, reports a recent AIDS article published by Lippincott
Williams & Wilkins; Vaginal Washing and Increased Risk of HIV-1 Acquisition among
African Women.
Kenyan HIV-1 seronegative female sex workers were enrolled in an open cohort study of risk
factors for HIV-1 acquisition. "This is the first prospective study to demonstrate a
significant association between vaginal washing and HIV-1 acquisition. A causal
association between vaginal washing and HIV-1 acquisition seems biologically
plausible," says R. Scott McClelland, International AIDS Research and Training
Program, University of Washington, Seattle, USA. Vaginal washing is highly prevalent,
having been reported in at least one third of women from various clinical settings and
regions in sub-Saharan Africa. There remains an urgent need for new initiatives to prevent
HIV-1 transmission to women, who account for the majority of new infections.
McClelland adds, "A thorough understanding of the norms and beliefs surrounding the
use of intravaginal practices in various populations is vital in order to develop
culturally appropriate intervention strategies." Where intravaginal practices are
widespread, even a modest increase in susceptibility could lead to a significant number of
women acquiring HIV-1 as a result of these practices.
Video - Is er een oplossing voor
Aids ?
Suppressed Medical Discovery cure for AIDS
:Dr Robert Beck
